Trademarks and Labeling. Roche shall own the global trademarks, logos, slogans and service marks used on or in connection with Licensed Products (“Global Trademarks”) worldwide, and shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all trademarks used on or in connection with Licensed Products worldwide. For Program 2 and Program 4, BPM shall have the right to provide input for the Global Trademarks which Roche shall reasonably consider and BPM shall either use the Global Trademarks or may use other trademarks or logos of its own choosing and at its own expense on or in connection with Licensed Products in the BPM Territory. Roche shall have the first right to enforce the Global Trademarks in the Roche Territory. For Program 2 and Program 4, BPM shall have the first right to enforce the Global Trademarks in the BPM Territory. If BPM does not timely enforce the Global Trademarks in the BPM Territory, then Roche shall have the right to enforce the Global Trademarks in the BPM Territory. Prior to commercialization of any Licensed Product in the BPM Territory bearing a Global Trademark, the Parties will enter into a trademark license agreement setting forth customary terms and conditions for using the Global Trademarks and ensuring quality and good will associated with the Global Trademarks. Notwithstanding the foregoing, BPM shall not be obligated to use such Global Trademarks and may instead select and use its own trademarks, logos, slogans and service marks on or in connection with Licensed Products for Program 2 and Program 4 in the BPM Territory (the “BPM Trademarks”). If BPM elects to use BPM Trademarks, BPM shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all such BPM Trademarks used on or in connection with Licensed Products. Roche shall have the right to obtain the International Non-proprietary Name (INN) from the World Health Organization and the US Adopted Name (USAN) from the US adopted Names Council (USANC) as the generic name(s) for the Licensed Products worldwide. The Parties shall consult with each other regarding the INN and USAN prior to Roche obtaining the INN and USAN, and Roche shall in good faith consider BPM’s input. In the case of Program 2 and Program 4, if BPM elects to use the Global Trademark, Roche shall grant BPM an exclusive, royalty-free license to use the Global Trademarks for the purpose of Exploiting the Licensed Products in the BPM Territory as permitted by this Agreement. Such trademark license shall be non-transferable, except that the BPM shall have the right to sublicense such rights to its Affiliates and Sublicensees in the BPM Territory. Roche shall maintain all registrations of such Global Trademarks worldwide, and BPM shall not file any identical or similar registrations or other filings in respect of any of such Global Trademarks without Roche’s prior written consent. BPM shall maintain all registrations of such BPM Trademarks, and Roche shall not file any identical registrations or other filings in respect of any of such BPM Trademarks without BPM’s prior written consent. Each Party shall use the Global Trademarks in accordance with sound trademark and trade name usage principles and in accordance with all Applicable Law as reasonably necessary to maintain the validity and enforceability of the Global Trademarks. BPM recognizes that Roche’s Global Trademarks represent a valuable asset of Roche, and that substantial recognition and goodwill are associated with such name, logo and trademarks. BPM hereby agrees that, without prior written authorization of Roche, it shall not use such Global Trademarks for any purpose except as expressly permitted under this Agreement. Roche recognizes that BPM Trademarks represent a valuable asset of BPM, and that substantial recognition and goodwill are associated with such name, logo and trademarks. Roche hereby agrees that, without prior written authorization of BPM, it shall not use such BPM Trademarks for any purpose except as expressly permitted under this Agreement.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Blueprint Medicines Corp), Collaboration and License Agreement (Blueprint Medicines Corp)
Trademarks and Labeling. The Parties shall attempt to use a uniform global trademark and logo for the Product; provided, that each Party may use its own trademarks and housemarks as it selects to promote the sale of the Product in the FMI Territory, with respect to FMI, and the Territory, with respect to Roche (collectively, excluding the housemarks, the “Product Trademarks”). The Parties shall agree on at least […***…] Product Trademarks for each Product, with […***…] of the trademarks being the global trademark and the other(s) being trademarks to be held in reserve in case the global trademark cannot be used in […***…] or more countries. The placement and size of a Party’s housemarks relative to Product Trademarks shall be approved by the JOC. Excluding the Roche housemarks, FMI shall own the any global trademarks, logos, slogans and service marks Product Trademarks used on or in connection with Licensed Products (“Global Trademarks”) worldwidein the Territory, and shall, at its sole cost, be responsible for selection, procurement, maintenance, enforcement and defense of all such global Product Trademarks. ***Confidential Treatment Requested*** Roche shall own its trademarks, including the Roche trademark and hexagon, and may use the Roche trademarks used on or in connection with Licensed Products worldwidethe Product as set forth in this Section. For Program 2 and Program 4, BPM shall have the right to provide input for the Global Trademarks which Roche shall reasonably consider and BPM shall either use the Global Trademarks or may use other trademarks or logos of its own choosing and at its own expense on or in connection with Licensed Products in the BPM Territory. Roche shall have the first right to enforce the Global Trademarks in the Roche Territory. For Program 2 and Program 4, BPM shall have the first right to enforce the Global Trademarks in the BPM Territory. If BPM does not timely enforce the Global Trademarks in the BPM Territory, then Roche shall have the right to enforce the Global Trademarks in the BPM Territory. Prior to commercialization of any Licensed Product in the BPM Territory bearing a Global Trademark, the Parties will enter into a trademark license agreement setting forth customary terms and conditions for using the Global Trademarks and ensuring quality and good will associated with the Global Trademarks. Notwithstanding the foregoing, BPM shall not be obligated to use such Global Trademarks and may instead select and use its own trademarks, logos, slogans and service marks on or in connection with Licensed Products for Program 2 and Program 4 in the BPM Territory (the “BPM Trademarks”). If BPM elects to use BPM Trademarks, BPM shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all such BPM Trademarks used on or in connection with Licensed Products. Roche shall have the right to obtain the International Non-proprietary Name (INN) from the World Health Organization and the US Adopted Name (USAN) from the US adopted Names Council (USANC) as the generic name(s) for the Licensed Products worldwide. The Parties shall consult with each other regarding the INN and USAN prior to Roche obtaining the INN and USAN, and Roche shall in good faith consider BPM’s input. In the case of Program 2 and Program 4, if BPM elects to use the Global Trademark, Roche shall grant BPM an exclusive, royalty-free license to use the Global Trademarks for the purpose of Exploiting the Licensed Products in the BPM Territory as permitted by this Agreement. Such trademark license shall be non-transferable, except that the BPM shall have the right to sublicense such rights to its Affiliates and Sublicensees in the BPM Territory. Roche shall maintain all registrations of such Global Trademarks worldwide, and BPM FMI shall not file any identical or similar registrations or other filings in respect of any such housemarks owned by Roche. FMI shall own its housemark and any trademark it selects to promote the sale of such Global Trademarks without Roche’s prior written consentthe Product in the FMI Territory. BPM shall maintain all registrations of such BPM Trademarks, and Roche shall not file any identical registrations or other filings in respect of any such trademarks and housemarks owned by FMI. Each Party shall maintain all registrations of such BPM Product Trademarks owned by it and the other Party shall not file any registrations or other filings in respect of any of such Product Trademark owned by the Product Trademark owning Party without BPMthe Product Trademark owning Party’s prior written consent. FMI shall use Commercially Reasonable Efforts to obtain and maintain Product Trademarks and to take reasonable measures to enforce oppositions and litigations in relation to the Product Trademarks. Each Party shall use the Global Product Trademarks in accordance with sound trademark and trade name usage principles and in accordance with all Applicable Law as reasonably necessary to maintain the validity and enforceability of the Global Product Trademarks. BPM Each Party recognizes that Roche’s Global Trademarks represent the trademarks owned by the other Party represents a valuable asset of Rochesuch other Party, and that substantial recognition and goodwill are associated with such name, logo and trademarks. BPM Each Party hereby agrees that, without prior written authorization of Rochethe other Party or as specifically permitted in this Agreement, it shall not use such Global Trademarks other Party’s trademarks for any purpose except as expressly permitted under this Agreementpurpose. Roche recognizes that BPM Trademarks represent a valuable asset of BPM, Each Party shall have the right to police its own trademarks and that substantial recognition and goodwill are associated with such name, logo and enforce its own trademarks. Roche hereby agrees thatEach Party shall have the right to audit the other Party, without prior written authorization its Affiliates, sublicensees/Sublicensees and contractors to ensure the quality of BPMthe Products to which the trademark is associated. In the event either Party becomes aware of any infringement of any Product Trademark by a Third Party, it such Party shall not use promptly notify the other Party and the Parties shall consult with each other and jointly determine the best way to prevent such BPM Trademarks for any purpose except as expressly permitted under this Agreementinfringement.
Appears in 2 contracts
Samples: Commercialization Agreement (Foundation Medicine, Inc.), Commercialization Agreement (Foundation Medicine, Inc.)
Trademarks and Labeling. The Parties shall attempt to use a uniform global trademark and logo for the Product; provided, that each Party may use its own trademarks and housemarks as it selects to promote the sale of the Product in the FMI Territory, with respect to FMI, and the Territory, with respect to Roche (collectively, excluding the housemarks, the “Product Trademarks”). The Parties shall agree on at least […***…] Product Trademarks for each Product, with […***…] of the trademarks being the global trademark and the other(s) being trademarks to be held in reserve in case the global trademark cannot be used in […***…] or more countries. The placement and size of a Party’s housemarks relative to Product Trademarks shall be approved by the JOC. Excluding the Roche housemarks, FMI shall own the any global trademarks, logos, slogans and service marks Product Trademarks used on or in connection with Licensed Products (“Global Trademarks”) worldwidein the Territory, and shall, at its sole cost, be responsible for selection, procurement, maintenance, enforcement and defense of all such global Product Trademarks. Roche shall own its trademarks, including the Roche trademark and hexagon, and may use the Roche trademarks used on or in connection with Licensed Products worldwidethe Product as set forth in this Section. For Program 2 and Program 4, BPM shall have the right to provide input for the Global Trademarks which Roche shall reasonably consider and BPM shall either use the Global Trademarks or may use other trademarks or logos of its own choosing and at its own expense on or in connection with Licensed Products in the BPM Territory. Roche shall have the first right to enforce the Global Trademarks in the Roche Territory. For Program 2 and Program 4, BPM shall have the first right to enforce the Global Trademarks in the BPM Territory. If BPM does not timely enforce the Global Trademarks in the BPM Territory, then Roche shall have the right to enforce the Global Trademarks in the BPM Territory. Prior to commercialization of any Licensed Product in the BPM Territory bearing a Global Trademark, the Parties will enter into a trademark license agreement setting forth customary terms and conditions for using the Global Trademarks and ensuring quality and good will associated with the Global Trademarks. Notwithstanding the foregoing, BPM shall not be obligated to use such Global Trademarks and may instead select and use its own trademarks, logos, slogans and service marks on or in connection with Licensed Products for Program 2 and Program 4 in the BPM Territory (the “BPM Trademarks”). If BPM elects to use BPM Trademarks, BPM shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all such BPM Trademarks used on or in connection with Licensed Products. Roche shall have the right to obtain the International Non-proprietary Name (INN) from the World Health Organization and the US Adopted Name (USAN) from the US adopted Names Council (USANC) as the generic name(s) for the Licensed Products worldwide. The Parties shall consult with each other regarding the INN and USAN prior to Roche obtaining the INN and USAN, and Roche shall in good faith consider BPM’s input. In the case of Program 2 and Program 4, if BPM elects to use the Global Trademark, Roche shall grant BPM an exclusive, royalty-free license to use the Global Trademarks for the purpose of Exploiting the Licensed Products in the BPM Territory as permitted by this Agreement. Such trademark license shall be non-transferable, except that the BPM shall have the right to sublicense such rights to its Affiliates and Sublicensees in the BPM Territory. Roche shall maintain all registrations of such Global Trademarks worldwide, and BPM FMI shall not file any identical or similar registrations or other filings in respect of any such housemarks owned by Roche. FMI shall own its housemark and any trademark it selects to promote the sale of such Global Trademarks without Roche’s prior written consentthe Product in the FMI Territory. BPM shall maintain all registrations of such BPM Trademarks, and Roche shall not file any identical registrations or other filings in respect of any such trademarks and housemarks owned by FMI. Each Party shall maintain all registrations of such BPM Product Trademarks owned by it, and the other Party shall not file any registrations or other filings in respect of any of such Product Trademark owned by the Product Trademark owning Party without BPMthe Product Trademark owning Party’s prior written consent. FMI shall use Commercially Reasonable Efforts to obtain and maintain Product Trademarks, and the Parties will reasonably cooperate with one another to take reasonable measures to enforce oppositions and litigations in relation to the Product Trademarks. Each Party shall use the Global Product Trademarks in accordance with sound trademark and trade name usage principles and in accordance with all Applicable Law as reasonably necessary to maintain the validity and enforceability of the Global Product Trademarks. BPM Each Party recognizes that Roche’s Global Trademarks represent the trademarks owned by the other Party represents a valuable asset of Rochesuch other Party, and that substantial recognition and goodwill are associated with such name, logo logo, and trademarks. BPM Each Party hereby agrees that, without prior written authorization of Rochethe other Party or as specifically permitted in this Agreement, it shall not use such Global Trademarks other Party’s trademarks for any purpose except as expressly permitted under this Agreementpurpose. Roche recognizes that BPM Trademarks represent a valuable asset of BPM, - 38 - ***Confidential Treatment Requested*** Each Party shall have the right to police its own trademarks and that substantial recognition and goodwill are associated with such name, logo and enforce its own trademarks. Roche hereby agrees thatEach Party shall have the right to audit the other Party, without prior written authorization its Affiliates, sublicensees/Sublicensees and contractors to ensure the quality of BPMthe Products to which the trademark is associated. In the event either Party becomes aware of any infringement of any Product Trademark by a Third Party, it such Party shall not use promptly notify the other Party and the Parties shall consult with each other and jointly determine the best way to prevent such BPM Trademarks for any purpose except as expressly permitted under this Agreementinfringement.
Appears in 1 contract
Samples: Commercialization Agreement (Foundation Medicine, Inc.)
Trademarks and Labeling. Roche shall own the global trademarks, logos, slogans and service marks used on or in connection with Licensed Products (“Global Trademarks”) worldwide, and shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all trademarks used on or in connection with Licensed Products worldwide. For Program 2 and Program 4, BPM shall have the right to provide input for the Global Trademarks which Roche shall reasonably consider and BPM shall either use the Global Trademarks or may use other trademarks or logos of its own choosing and at its own expense on or in connection with Licensed Products in the BPM Territory. Roche shall have the first right to enforce the Global Trademarks in the Roche Territory. For Program 2 and Program 4, BPM shall have the first right to enforce the Global Trademarks in the BPM Territory. If BPM does not timely enforce the Global Trademarks in the BPM Territory, then Roche shall have the right to enforce the Global Trademarks in the BPM Territory. Prior to commercialization of any Licensed Product in the BPM Territory bearing a Global Trademark, the Parties will enter into a trademark license agreement setting forth customary terms and conditions for using the Global Trademarks and ensuring quality and good will associated with the Global Trademarks. Notwithstanding the foregoing, BPM shall not be obligated to use such Global Trademarks and may instead select and use its own trademarks, logos, slogans and service marks on or in connection with Licensed Products for Program 2 and Program 4 in the BPM Territory (the “BPM Trademarks”). If BPM elects to use BPM Trademarks, BPM shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all such BPM Trademarks used on or in connection with Licensed Products. Roche shall have the right to obtain the International Non-proprietary Name (INN) from the World Health Organization and the US Adopted Name (USAN) from the US adopted Names Council (USANC) as the generic name(s) for the Licensed Products worldwide. The Parties shall consult with each other regarding the INN and USAN prior to Roche obtaining the INN and USAN, and Roche shall in good faith consider BPM’s input. In the case of Program 2 and Program 4, if BPM elects to use the Global Trademark, Roche shall grant BPM an exclusive, royalty-free license to use the Global Trademarks for the purpose of Exploiting the Licensed Products in the BPM Territory as permitted by this Agreement. Such trademark license shall be non-transferable, except that the BPM shall have the right to sublicense such rights to its Affiliates and Sublicensees in the BPM Territory. Roche shall maintain all registrations of such Global Trademarks worldwide, and BPM shall not file any identical or similar registrations or other filings in respect of any of such Global Trademarks without Roche’s prior written consent. BPM shall maintain all registrations of such BPM Trademarks, and Roche shall not file any identical registrations or other filings in respect of any of such BPM Trademarks without BPM’s prior written consent. Each Party shall use the Global Trademarks in accordance with sound trademark and trade name usage principles and in accordance with all Applicable Law as reasonably necessary to maintain the validity and enforceability of the Global Trademarks. BPM recognizes that Roche’s Global Trademarks represent a valuable asset of Roche, and that substantial recognition and goodwill are associated with such name, logo and trademarks. BPM hereby agrees that, without prior written authorization of Roche, it shall not use such Global Trademarks for any purpose except as expressly permitted under this Agreement. Roche recognizes that BPM Trademarks represent a valuable asset of BPM, and that substantial recognition and goodwill are associated with such name, logo and trademarks. Roche hereby agrees that, without prior written authorization of BPM, it shall not use such BPM Trademarks for any purpose except as expressly permitted under this Agreement.
Appears in 1 contract
Trademarks and Labeling. The Parties shall attempt to use a uniform global trademark and logo for the Product; provided, that each Party may use its own trademarks and housemarks as it selects to promote the sale of the Product in the FMI Territory, with respect to FMI, and the Territory, with respect to Roche (collectively, excluding the housemarks, the “Product Trademarks”). The Parties shall agree on at least […***…] Product Trademarks for each Product, with […***…] of the trademarks being the global trademark and the other(s) being trademarks to be held in reserve in case the global trademark cannot be used in […***…] or more countries. The placement and size of a Party’s housemarks relative to Product Trademarks shall be approved by the JOC. Excluding the Roche housemarks, FMI shall own the any global trademarks, logos, slogans and service marks Product Trademarks used on or in connection with Licensed Products (“Global Trademarks”) worldwidein the Territory, and shall, at its sole cost, be responsible for selection, procurement, maintenance, enforcement and defense of all such global Product Trademarks. Roche shall own its trademarks, including the Roche trademark and hexagon, and may use the Roche trademarks used on or in connection with Licensed Products worldwidethe Product as set forth in this Section. For Program 2 and Program 4, BPM shall have the right to provide input for the Global Trademarks which Roche shall reasonably consider and BPM shall either use the Global Trademarks or may use other trademarks or logos of its own choosing and at its own expense on or in connection with Licensed Products in the BPM Territory. Roche shall have the first right to enforce the Global Trademarks in the Roche Territory. For Program 2 and Program 4, BPM shall have the first right to enforce the Global Trademarks in the BPM Territory. If BPM does not timely enforce the Global Trademarks in the BPM Territory, then Roche shall have the right to enforce the Global Trademarks in the BPM Territory. Prior to commercialization of any Licensed Product in the BPM Territory bearing a Global Trademark, the Parties will enter into a trademark license agreement setting forth customary terms and conditions for using the Global Trademarks and ensuring quality and good will associated with the Global Trademarks. Notwithstanding the foregoing, BPM shall not be obligated to use such Global Trademarks and may instead select and use its own trademarks, logos, slogans and service marks on or in connection with Licensed Products for Program 2 and Program 4 in the BPM Territory (the “BPM Trademarks”). If BPM elects to use BPM Trademarks, BPM shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all such BPM Trademarks used on or in connection with Licensed Products. Roche shall have the right to obtain the International Non-proprietary Name (INN) from the World Health Organization and the US Adopted Name (USAN) from the US adopted Names Council (USANC) as the generic name(s) for the Licensed Products worldwide. The Parties shall consult with each other regarding the INN and USAN prior to Roche obtaining the INN and USAN, and Roche shall in good faith consider BPM’s input. In the case of Program 2 and Program 4, if BPM elects to use the Global Trademark, Roche shall grant BPM an exclusive, royalty-free license to use the Global Trademarks for the purpose of Exploiting the Licensed Products in the BPM Territory as permitted by this Agreement. Such trademark license shall be non-transferable, except that the BPM shall have the right to sublicense such rights to its Affiliates and Sublicensees in the BPM Territory. Roche shall maintain all registrations of such Global Trademarks worldwide, and BPM FMI shall not file any identical or similar registrations or other filings in respect of any such housemarks owned by Roche. FMI shall own its housemark and any trademark it selects to promote the sale of such Global Trademarks without Roche’s prior written consentthe Product in the FMI Territory. BPM shall maintain all registrations of such BPM Trademarks, and Roche shall not file any identical registrations or other filings in respect of any such trademarks and housemarks owned by FMI. Each Party shall maintain all registrations of such BPM Product Trademarks owned by it, and the other Party shall not file any registrations or other filings in respect of any of such Product Trademark owned by the Product Trademark owning Party without BPMthe Product Trademark owning Party’s prior written consent. FMI shall use Commercially Reasonable Efforts to obtain and maintain Product Trademarks, and the Parties will reasonably cooperate with one another to take reasonable measures to enforce oppositions and litigations in relation to the Product Trademarks. Each Party shall use the Global Product Trademarks in accordance with sound trademark and trade name usage principles and in accordance with all Applicable Law as reasonably necessary to maintain the validity and enforceability of the Global Product Trademarks. BPM Each Party recognizes that Roche’s Global Trademarks represent the trademarks owned by the other Party represents a valuable asset of Rochesuch other Party, and that substantial recognition and goodwill are associated with such name, logo logo, and trademarks. BPM Each Party hereby agrees that, without prior written authorization of Rochethe other Party or as specifically permitted in this Agreement, it shall not use such Global Trademarks other Party’s trademarks for any purpose except as expressly permitted under this Agreementpurpose. Roche recognizes that BPM Trademarks represent a valuable asset of BPM, Each Party shall have the right to police its own trademarks and that substantial recognition and goodwill are associated with such name, logo and enforce its own trademarks. Roche hereby agrees thatEach Party shall have the right to audit the other Party, without prior written authorization its Affiliates, sublicensees/Sublicensees and contractors to ensure the quality of BPMthe Products to which the trademark is associated. In the event either Party becomes aware of any infringement of any Product Trademark by a Third Party, it such Party shall not use promptly notify the other Party and the Parties shall consult with each other and jointly determine the best way to prevent such BPM Trademarks for any purpose except as expressly permitted under this Agreementinfringement.
Appears in 1 contract
Samples: Commercialization Agreement (Foundation Medicine, Inc.)
Trademarks and Labeling. Roche shall own the global trademarks, logos, slogans and service marks used on or in connection with Licensed Products (“Global Trademarks”) worldwide, and shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all trademarks used on or in connection with Licensed Products worldwide. For Program 2 and Program 4, BPM Regeneron shall have the right and responsibility to provide input for the Global Trademarks which Roche shall reasonably consider and BPM shall either use the Global Trademarks or may use other trademarks or logos of its own choosing and at its own expense on or in connection with Licensed Products in the BPM Territory. Roche shall have the first right to enforce the Global Trademarks in the Roche Territory. For Program 2 and Program 4create, BPM shall have the first right to enforce the Global Trademarks in the BPM Territory. If BPM does not timely enforce the Global Trademarks in the BPM Territory, then Roche shall have the right to enforce the Global Trademarks in the BPM Territory. Prior to commercialization of any Licensed Product in the BPM Territory bearing a Global Trademark, the Parties will enter into a trademark license agreement setting forth customary terms and conditions for using the Global Trademarks and ensuring quality and good will associated with the Global Trademarks. Notwithstanding the foregoing, BPM shall not be obligated to use such Global Trademarks and may instead select and use its own trademarks, logos, slogans and service marks on or in connection with Licensed Products for Program 2 and Program 4 in the BPM Territory (the “BPM Trademarks”). If BPM elects to use BPM Trademarks, BPM shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all such BPM Trademarks used on or in connection with Licensed Products. Roche shall have the right to obtain the International Non-proprietary Name (INN) from the World Health Organization and the US Adopted Name (USAN) from the US adopted Adopted Names Council (USANC) as the generic name(s) for the Licensed Products worldwideProducts. The Parties JOC shall consult with each select one or more global trademark(s) for use on the Product in the Territory, including any accompanying logos, slogans, trade names, domain names, trade dress or other regarding indicia of origin, excluding the INN corporate names and USAN prior to Roche obtaining logos of either Party (the INN and USAN“Global Trademarks”). If, and Roche shall in good faith consider BPM’s input. In the case under Applicable Law, none of Program 2 and Program 4, if BPM elects to use the Global Trademark, Roche shall grant BPM an exclusive, royalty-free license to use the Global Trademarks for a Product can be used for the purpose commercialization of Exploiting the Licensed Products such Product in a country in the BPM Territory as permitted by this Agreement. Such trademark license Roche Territory, the JOC shall be non-transferablediscuss and select one (1) or more alternative trademarks, except including any accompanying logos, slogans, trade names, domain names, trade dress or other indicia of origin, for the commercialization of such Product in such country (each, an “Alternative Product Trademark”); provided, that if the BPM Parties are unable to agree on such Alternative Product Trademarks, the JOC shall have the right to sublicense select such rights to its Affiliates and Sublicensees Alternative Product Trademarks. Regeneron shall own all Global Trademarks in the BPM Regeneron Territory, and shall, at its sole cost, be responsible for procurement, maintenance, enforcement and defense of all Global Trademarks in the Regeneron Territory. Roche shall maintain own all registrations of such Global Trademarks worldwideand, if applicable, Alternative Product Trademarks, in the Roche Territory, and BPM shall not file any identical or similar registrations or other filings in respect shall, at its sole cost, be responsible for procurement, maintenance, enforcement and defense of any of such Global Trademarks without Roche’s prior written consent. BPM shall maintain all registrations of such BPM and if applicable, Alternative Product Trademarks, and in the Roche shall not file any identical registrations or other filings in respect of any of such BPM Trademarks without BPM’s prior written consentTerritory. Each Party shall keep the other Party reasonably informed regarding any material, substantive issue or any opposition, cancellation, invalidity or other proceeding that may be raised or asserted against any application or registration for a Global Trademark, or, with respect to Roche if applicable, Alternative Product Trademark in its Respective Territory. Each Party and its Affiliates and its and their Sublicensees shall not license (or, as applicable, sublicense) rights to use, or otherwise transfer ownership of the Global Trademark(s) or, if applicable with respect to Roche, Alternative Product Trademarks, without the prior written consent of the other Party except with respect to any manufacturing or development activities permitted hereunder. Each Party and its Affiliates and its and their Sublicensees shall only utilize the Global Trademark(s) or, if applicable with respect to Roche, Alternative Product Trademarks, on materials related to the Products in its Respective Territory (including package inserts, packaging, trade packaging, internet pages, social media, advertising and promotional materials used or distributed in connection with the Products). Each Party agrees that at no time during the Agreement Term will it or any of its Affiliates attempt to use or register in its Respective Territory any trademarks, trade dress, service marks, trade names or domain names confusingly similar to any Global Trademark or, if applicable with respect to Roche, any Alternative Product Trademark, in relation to a product that is not a Product, or take any other action that damages or dilutes the rights to, or goodwill associated with, any Global Trademark or, if applicable with respect to Roche, any Alternative Product Trademark. All use of the Global Trademarks and Alternative Product Trademarks, as applicable, by a Party or its Affiliates or Sublicensees, or, where applicable, its or their distributors, shall be in accordance with sound (a) rules established by the JOC, if any, and (b) quality standards established by the respective trademark and trade name usage principles and owner, in accordance with all Applicable Law as each case ((a) or (b)), that are reasonably necessary in order to maintain preserve the validity and enforceability of the Global Trademarks and Alternative Product Trademarks. BPM recognizes that Roche’s Global Trademarks represent a valuable asset of Roche, and that substantial recognition and goodwill are associated with such name, logo and trademarks. BPM hereby agrees that, without prior written authorization of Roche, it shall not use such Global Trademarks for any purpose except as expressly permitted under this Agreement. Roche recognizes that BPM Trademarks represent a valuable asset of BPM, and that substantial recognition and goodwill are associated with such name, logo and trademarks. Roche hereby agrees that, without prior written authorization of BPM, it shall not use such BPM Trademarks for any purpose except as expressly permitted under this Agreementapplicable.
Appears in 1 contract
Samples: License Agreement (Regeneron Pharmaceuticals, Inc.)
Trademarks and Labeling. The Parties shall attempt to use a uniform global trademark and logo for the Product; provided, that each Party may use its own trademarks and housemarks as it selects to promote the sale of - 36 - ***Confidential Treatment Requested*** the Product in the FMI Territory, with respect to FMI, and the Territory, with respect to Roche (collectively, excluding the housemarks, the “Product Trademarks”). The Parties shall agree on at least […***…] Product Trademarks for each Product, with […***…] of the trademarks being the global trademark and the other(s) being trademarks to be held in reserve in case the global trademark cannot be used in […***…] or more countries. The placement and size of a Party’s housemarks relative to Product Trademarks shall be approved by the JOC. Excluding the Roche housemarks, FMI shall own the any global trademarks, logos, slogans and service marks Product Trademarks used on or in connection with Licensed Products (“Global Trademarks”) worldwidein the Territory, and shall, at its sole cost, be responsible for selection, procurement, maintenance, enforcement and defense of all such global Product Trademarks. Roche shall own its trademarks, including the Roche trademark and hexagon, and may use the Roche trademarks used on or in connection with Licensed Products worldwidethe Product as set forth in this Section. For Program 2 and Program 4, BPM shall have the right to provide input for the Global Trademarks which Roche shall reasonably consider and BPM shall either use the Global Trademarks or may use other trademarks or logos of its own choosing and at its own expense on or in connection with Licensed Products in the BPM Territory. Roche shall have the first right to enforce the Global Trademarks in the Roche Territory. For Program 2 and Program 4, BPM shall have the first right to enforce the Global Trademarks in the BPM Territory. If BPM does not timely enforce the Global Trademarks in the BPM Territory, then Roche shall have the right to enforce the Global Trademarks in the BPM Territory. Prior to commercialization of any Licensed Product in the BPM Territory bearing a Global Trademark, the Parties will enter into a trademark license agreement setting forth customary terms and conditions for using the Global Trademarks and ensuring quality and good will associated with the Global Trademarks. Notwithstanding the foregoing, BPM shall not be obligated to use such Global Trademarks and may instead select and use its own trademarks, logos, slogans and service marks on or in connection with Licensed Products for Program 2 and Program 4 in the BPM Territory (the “BPM Trademarks”). If BPM elects to use BPM Trademarks, BPM shall, at its sole cost, be responsible for selection, procurement, maintenance, and defense of all such BPM Trademarks used on or in connection with Licensed Products. Roche shall have the right to obtain the International Non-proprietary Name (INN) from the World Health Organization and the US Adopted Name (USAN) from the US adopted Names Council (USANC) as the generic name(s) for the Licensed Products worldwide. The Parties shall consult with each other regarding the INN and USAN prior to Roche obtaining the INN and USAN, and Roche shall in good faith consider BPM’s input. In the case of Program 2 and Program 4, if BPM elects to use the Global Trademark, Roche shall grant BPM an exclusive, royalty-free license to use the Global Trademarks for the purpose of Exploiting the Licensed Products in the BPM Territory as permitted by this Agreement. Such trademark license shall be non-transferable, except that the BPM shall have the right to sublicense such rights to its Affiliates and Sublicensees in the BPM Territory. Roche shall maintain all registrations of such Global Trademarks worldwide, and BPM FMI shall not file any identical or similar registrations or other filings in respect of any such housemarks owned by Roche. FMI shall own its housemark and any trademark it selects to promote the sale of such Global Trademarks without Roche’s prior written consentthe Product in the FMI Territory. BPM shall maintain all registrations of such BPM Trademarks, and Roche shall not file any identical registrations or other filings in respect of any such trademarks and housemarks owned by FMI. Each Party shall maintain all registrations of such BPM Product Trademarks owned by it, and the other Party shall not file any registrations or other filings in respect of any of such Product Trademark owned by the Product Trademark owning Party without BPMthe Product Trademark owning Party’s prior written consent. FMI shall use Commercially Reasonable Efforts to obtain and maintain Product Trademarks, and the Parties will reasonably cooperate with one another to take reasonable measures to enforce oppositions and litigations in relation to the Product Trademarks. Each Party shall use the Global Product Trademarks in accordance with sound trademark and trade name usage principles and in accordance with all Applicable Law as reasonably necessary to maintain the validity and enforceability of the Global Product Trademarks. BPM Each Party recognizes that Roche’s Global Trademarks represent the trademarks owned by the other Party represents a valuable asset of Rochesuch other Party, and that substantial recognition and goodwill are associated with such name, logo logo, and trademarks. BPM Each Party hereby agrees that, without prior written authorization of Rochethe other Party or as specifically permitted in this Agreement, it shall not use such Global Trademarks other Party’s trademarks for any purpose except as expressly permitted under this Agreementpurpose. Roche recognizes that BPM Trademarks represent a valuable asset of BPM, Each Party shall have the right to police its own trademarks and that substantial recognition and goodwill are associated with such name, logo and enforce its own trademarks. Roche hereby agrees thatEach Party shall have the right to audit the other Party, without prior written authorization its Affiliates, sublicensees/Sublicensees and contractors to ensure the quality of BPMthe Products to which the trademark is associated. In the event either Party becomes aware of any infringement of any Product Trademark by a Third Party, it such Party shall not use promptly notify the other Party and the Parties shall consult with each other and jointly determine the best way to prevent such BPM Trademarks for any purpose except as expressly permitted under this Agreementinfringement.
Appears in 1 contract
Samples: www.sec.gov